Lab21 Sells SC Labs, Assets Acquired by Selah Genomics | GenomeWeb

NEW YORK (GenomeWeb News) – The Cambridge, UK-based personalized diagnostics company Lab 21 said today that it has sold its lab operations in South Carolina to a new entity formed by existing local Lab21 executives who will launch a new company called Selah Genomics.

The sale of the clinical service lab operations in Greenville and Columbia, which Lab21 has run for three years, will remove a loss-making business from the company's books, but will not impact the company's core strategies in the US market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.